You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumors Cancer (1)

Head and Neck Cancer (1)

Pancreatic Cancer (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

AbbVie (3)

Collaborator

Intervention

abbv-927 (3)

abbv-181 (2)

abbv-368 (1)

budiglimab (1)

modified folfirinox (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

abbv-927

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

Active, not recruiting

Advanced Solid Tumors Cancer

ABBV-927
ABBV-181

Los Angeles, California
+21 more

Jan 20, 2023

Pancreatic Cancer Trial in Worldwide (ABBV-927, Budiglimab, modified FOLFIRINOX)

Recruiting

Pancreatic Cancer

ABBV-927
+2 more

Springdale, Arkansas
+23 more

May 23, 2022

Head Neck Cancer Trial in Boston, Ann Arbor, Houston (ABBV-181, ABBV-368, ABBV-927)

Terminated

Head and Neck Cancer

ABBV-181
+2 more

Boston, Massachusetts
+2 more

Dec 30, 2020